Rongliang Lou
Executive Director Innovent Biologics
Seminars
Tuesday 4th November 2025
Harnessing the Power of Bispecific ADCs, Novel & Dual Payload Conjugates to Develop Next-Generation ADCs
2:00 pm
- Highlighting design and preclinical development of IBI3005 bispecific ADC targeting EGFR & HER3
- Assessing rationale and performance of ADCs with dual targeting and dual payload design versus classical design
- Leveraging novel TOP1i payloads in bispecific and dual-payload ADCs
